+23.0%
GSK vs AME
+26.3%
-3.3%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.0% | -0.9% | -0.2% | -0.8% |
| 7D | -5.4% | 0.0% | -5.4% | -5.4% |
| 30D | -4.6% | -8.6% | +4.0% | -2.5% |
| 3M | -5.1% | +5.8% | -10.9% | -7.9% |
| 6M | -11.4% | +3.8% | -15.3% | -13.7% |
| YTD | +0.7% | +14.4% | -13.7% | -5.9% |
| 1Y | +23.0% | +25.8% | -2.8% | +11.6% |
| All | +23.0% | +26.3% | -3.3% | +11.6% |
Cumulative growth
Daily Returns
Daily percentage return beside AME.
Daily Out/Under-Performance
Portfolio return minus AME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling